1/101
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
secondary immunodeficiency
not caused by genetic defect, but rather due to infections, medications, or other external factors that impair the immune system.
nausea, diarrhea, GI issues
common antifungal ADRs
acquired C1 inhibitor dysfunction
late-onset angioedema characterized by recurrent swelling episodes.
primary immunodeficiency
genetic defect that impairs innate or adaptive immunity
hereditary angioadema
example of primary immunodeficiency
late complement defects
reelate to an increased susceptibility to meningococcal disease (defects in C5-C9)
lupus and glomerulonephritis, invasive infections with encapsulated organisms (s. pneumoniae, H. influenzae, n. meningitidis)
examples of early classical pathway defects
bradykinin
small peptide causes blood vessel dilation and increased permeability, causes fluid leak into tissues (edema)
stops production of bradykinin
how does C1 inhibitor effect bradykinin
hereditary angioadema
cause by C1 inhibitor (C1-INH) deficiency/abscence
hereditary angioadema
rapid swelling triggered by trauma, surgery, or emotional stress, hereditary or acquired, dental procedures can cause life-threatening swelling of the airways
neutropenia
low neutrophil count, infections, fever, skin infections, mouth sores, swelling/inflammation of gums
leukocyte adhesion deficiency
elevated WBC count, skin and soft tissue infections, affects tethering/rolling of adhesion of neutrophils, periodontitis, oral ulcers, and poor wound healing
chronic granulomatous disease
defects in componenets of NADPH oxidase complex, neutrophil deficiency cannot make ROS
chronic granulomatous disease
skin and soft tissue infection with catalase + organisms (staph, seratia, aspergillus, burkhoderia)
periodontitis
leukocyte adhesion deficiency could result in
lupus (systemic lupus erythematosus)
early complement deficiency often results in
Neisserria
defects in late complement pathway are associated almost exclusively with infections by which bacteria
neutropenia
Lack of first responders in this immunodeficiency could be due to congenital or acquired causes, but regardless, patients with this condition are susceptible to infections by Gram-negative rods.
type IV
hypersensitivity reaction initiated by antigen-activated T lymphocytes
conjugated vaccines
induce a strong immune response against infections by bacteria with polysaccharide capsules and have contributed to the significant reduction of bacterial meningitis.
nystatin
polyene, forms pores in fungal cell membranes
polyene
nystatin drug class
miconazole/clotrimazoles
azoles (imidazoles), forms pores in fungal cell membranes
azoles (imidazoles)
miconazole/clotimazole drug class
Chlorohexidine mouthwash
bisbiguanides, Disrupts bacterial and fungal membranes with single use; disrupts DNA/RNA function with chronic use
bisbiguanides
chlorohexidine mouthwash drug class
Fluconazole (and other -conazoles)
azoles (triazoles), block fungal CyP450 enzymes involved in ergosterol synthesis, disrupting cell membrane
azoles (triazoles)
fluconazole drug class
Echinocandins, Flucytosine (pyrimidine analogs), ibrexfungerp (triterpenoids)
fungal membrane and DNA/RNA disrupter
fluconazole
Which antifungal agent has a ADR of QT prolongation
increased risk of TdP (torsades de pointe (arrhythmia))
What is the risk of taking more than one QT-prolonging drug
echinocandins, Flucytosine, ibrexafugerp
Antifungal agents reserved for immunosuppressed inpatients
replicating viruses (not latent)
What do antiviral agents act on
vaccines
What is the best prevention of viruses
adenovirus, pox virus, herpes virus
DNA virus examples
DNA due to stability
What kind of viruses are easier to prevent with vaccines and why
coronavirus, retrovirus, influenza
Examples of RNA viruses
Viral entry inhibitors
block viral attachment or entry
CCR-5 antagonists, fusion inhibitors, attachment inhibitors
Examples of viral entry inhibitors
Interferons
block entry into cell via endocytosis
Adamantanes
inhibit uncoating of virus
Nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTI and NNRTI)
block viral DNA or RNA replication
Integrase strand receptor inhibitors
prevent integration of retrovirus DNA into host cell DNA
Protease inhibitors
block viral protein synthesis
Assembly inhibitors
block viral protein capsid assembly
Neuroamisdase inhibitors
block viral exit from cell
Acyclovir/valacyclovir
nucleoside reverse transcriptase inhibits guanosine incorporation into cell
nucleoside inhibitors, competitively bind DNA during transcription (transcription termination)
Mechanism of action for most agents used to treat herpesviruses
acyclovir
Herpes antiviral safe to use during pregnancy
acyclovir/valacyclovir, famciclovir
agents used to treat HSV (herpes simplex virus)
supportive care only (no antiviral agent approved)
Treatment of Epstein barr virus
block viral RNA replication (baloxavir) or inhibit virus exit (amivers)
MOA of influenza agents
within 2 days of symptoms onset
When to start influenza treatment
baloxavir
Influenza antiviral taken as single oral dose
nausea, vomiting, headache
ADRs of influenza antiviral agents (reduced with baloxavir)
niramatrelvir and ritonavir (paxlovid)
What agents confer 89% relative risk reduction (RRR) of COVID hospitalization/death
block DNA/RNA replication and protein synthesis
MOA of COVID anti viral treatments
remdesivir
What agent confers 87% RRR of COVID hospitalization/death
dysgeusia, diarrhea, nausea
ADRs of Covid antiviral
NSAIDs (non steroidal anit-inflammatory drugs)
inhibits prostaglandin, prostacyclin and thromboxane production (Cox pathway)
Corticosteroids
inhibit prostaglandin, prostacyclin, thromboxane, leukotriene, and interleukin production, (blocks arachidonic acid production)
prednisone, dexamethasone, triacinolone
Corticosteroid examples
autoimmunity
immune system attacks it’s own healthy cells (rheumatoid arthritis)
celecoxib
NSAID with lowest risk of GI effects
ibuprofen, naproxen, celecoxib
NSAID examples
Direct immunosuppressants
block IL-2 production and interfere with T cell function
infection, hypertension
ADRs of direct immunosupressants
Biological response modifiers
target specific step in immune process
prolonged bleeding, effects on GI tract
Concern in patients taking chronic NSAIDs
delayed wound healing, hyperglycemia (corticosteroid only)
Concern in patients taking corticosteroids or direct immunosupressants
polio (IPV), hepatitis A, influenza (shot)
Inactivated vaccine examples
tetanus, diptheria
Toxoid vaccine examples
Hep B, HPV, shingles, pertussis, Hib, pneumococcal polysac, meningococcal polysac
Subunit vaccine examples
Ebola, COVID-19
Viral vector vaccine examples
MMR, varicella, rotavirus, influenza (nasal spray), polio
Live-attenuated vaccine example
inactivated vaccine
Relatively easy and inexpensive to make, safe
toxoid vaccine
Typically requires intermittent boosters to maintain antibody level
subunit vaccine
Suitable for those who should not receive “live” vaccine
Pneumococcal polysaccharide vaccine
created from mixed polysaccharides from 23 diff strep pneumoniae serotypes
Recombinant vaccine (subunit)
Hep B vaccine, created from portion of HBsAG expressed recombinantly in yeast
live-attenuated vaccine
Has potential to revert to fully pathogenic form
live-attenuated
Long term immunization in which host cell processes viral antigens to allow T and B cell response
Conjugated vaccine
isolating polysaccharide capsule and adding protein component, Hib
Type I
immediate, IgE/mast cell meditaed
Type II
Ab-mediated, IgG or IgM
Type III
immune complex-mediated, IgG or IgM and antigen complex
Type IV
delayed-type, T Cell mediated
systemic anaphylaxis, Bronchial asthma, urticaria (hives), atopic dermatitis, allergic rhinitis (hay fever), food allergies
Allergic disease of Type I
Transfusion reactions, Autoimmune hemolytic anemia, Goodpasture syndrome, Drug hypersensitivity reactions, graves disease (thyroid disease), Pemphigus vulgaris
Type II hypersensitivites
systematic lupus erythematosus, hypersensitivity pneumonitis, post streptococcal glomeronephritis
hypersensitivities of Type III
granulomatous, contact dermatitis, rheumatoid arthritis, drug fever
Allergic disease of Type IV
Corticosteroids
supresses inflammation, suppress synthesis of prostaglandins and leukotriense by mast cells
Antihistamine
blocks histamine, reduce inflammation, type I hypersensitivity treatment
Epinephrine
relax bronchial muscle and constriction of blood vessels, systematic anaphylaxis treatment
Albuterol
used for asthma, opens bronchioles, type I hypersensitivity treatment
Pseudoephedrine
nasal decongestant, hay fever treatment
Type I
Latex allergy that requires immediate action
type IV
Hypersensitivity not affected by agammaglobulinemia (failure to develop mature B cells)
Patients never vaccinated nor had COVID infection
what group of patients newly diagnosed with a COVID infection would most benefit from nirmatrelvir + ritonavir (Paxlovid)?